Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M76.0Revenue $M31.2Net Margin (%)92.4Z-Score9.0
Enterprise Value $M41.4EPS $0.7Operating Margin %92.4F-Score7
P/E(ttm))2.6Cash Flow Per Share $-0.3Pre-tax Margin (%)92.6Higher ROA y-yY
Price/Book2.610-y EBITDA Growth Rate %0Quick Ratio6.9Cash flow > EarningsY
Price/Sales2.55-y EBITDA Growth Rate %0Current Ratio6.9Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %58.5ROA % (ttm)133Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)148Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M44.2ROI % (ttm)1.9Gross Margin Increase y-yN

Gurus Latest Trades with ENZN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ENZNMichael Price 2014-12-31 Sold Out -0.05%$0.89 - $1.21
($1.05)
$ 1.7239%Sold Out0
ENZNMichael Price 2014-09-30 Reduce-0.05%$1.02 - $1.75
($1.25)
$ 1.7227%Reduce -54.56%340,000
ENZNGeorge Soros 2014-09-30 Sold Out $1.02 - $1.75
($1.25)
$ 1.7227%Sold Out0
ENZNGeorge Soros 2014-06-30 Buy $0.81 - $1.18
($0.95)
$ 1.7245%New holding50,123
ENZNSeth Klarman 2014-03-31 Sold Out -0.14%$0.861 - $1.26
($1.04)
$ 1.7240%Sold Out0
ENZNSeth Klarman 2013-12-31 Reduce-0.16%$1.15 - $1.74
($1.54)
$ 1.7210%Reduce -43.60%4,337,858
ENZNCharles Brandes 2013-06-30 Add0.02%$1.6 - $3.95
($2.93)
$ 1.72-70%Add 184.52%1,026,723
ENZNCharles Brandes 2013-03-31 Add0.01%$3.79 - $4.99
($4.54)
$ 1.72-164%Add 432.17%360,865
ENZNJean-Marie Eveillard 2012-12-31 Sold Out -0.01%$4.35 - $7
($6.03)
$ 1.72-251%Sold Out0
ENZNCharles Brandes 2012-12-31 Add$4.35 - $7
($6.03)
$ 1.72-251%Add 35.19%67,810
ENZNJean-Marie Eveillard 2012-09-30 Reduce-0.02%$6.42 - $7.17
($6.8)
$ 1.72-295%Reduce -56.42%490,142
ENZNCharles Brandes 2012-06-30 Add$5.87 - $7.06
($6.44)
$ 1.72-274%Add 58.41%51,070
ENZNCharles Brandes 2012-03-31 Buy $6.54 - $7.82
($6.67)
$ 1.72-288%New holding32,240
ENZNCarl Icahn 2011-09-30 Add0.07%$7.24 - $10.37
($8.8)
$ 1.72-412%Add 25.00%5,904,863
ENZNGeorge Soros 2011-06-30 Sold Out $9.97 - $11.81
($10.79)
$ 1.72-527%Sold Out0
ENZNMichael Price 2011-03-31 Add0.16%$10.14 - $12.48
($11.15)
$ 1.72-548%Add 16.65%700,000
ENZNGeorge Soros 2011-03-31 Reduce$10.14 - $12.48
($11.15)
$ 1.72-548%Reduce -52.50%30,400
ENZNCarl Icahn 2010-12-31 Add0.41%$10.5 - $12.5
($11.36)
$ 1.72-560%Add 67.70%4,723,891
ENZNSeth Klarman 2010-09-30 Add0.14%$10.25 - $11.28
($10.74)
$ 1.72-524%Add 2.03%10,382,698
ENZNGeorge Soros 2010-09-30 Add0.01%$10.25 - $11.28
($10.74)
$ 1.72-524%Add 481.74%66,900
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ENZN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ENZN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LEBUHN ROBERTDirector 2013-09-19Sell55,926$1.72-10.47view
LEBUHN ROBERTDirector 2012-08-14Sell5,820$6.58-76.6view
LEBUHN ROBERTDirector 2012-08-10Sell1,933$6.58-76.6view
HEBARD GEORGEInterim PEO and Interim COO 2012-06-20Buy5,000$6.88-77.62view
Rackear Andrew D.VP and General Counsel 2012-06-05Sell1,614$6.81-77.39view
Conover CharlesSVP, R&D Program Management 2012-06-05Sell25,000$6.78-77.29view
Young Richard ADirector 2012-03-15Sell2,000$6.92-77.75view
Rackear Andrew D.VP and General Counsel 2011-11-10Sell3,766$6.68-76.95view
Buchbinder AbyVP, Clinical Development 2011-11-08Sell2,700$7.06-78.19view
LEBUHN ROBERTDirector 2011-06-01Sell8,702$10.57-85.43view

Press Releases about ENZN :

    Quarterly/Annual Reports about ENZN:

    News about ENZN:

    Articles On GuruFocus.com
    Baupost’s Seth Klarman Takes 10% Stake in Keryx Biopharmaceuticals May 12 2014 
    GuruFocus Real Time Picks of the Week Jan 10 2014 
    Seth Klarman Buys New Stock Kindred Biosciences, Cut Stake in Enzon Jan 10 2014 
    Billionaires Hold Bargains, 40% Off or More Sep 11 2013 
    Charles Brandes Top Second Quarter Portfolio Changes Aug 09 2013 
    First Pacific Advisors’ Top New Buys Aug 08 2012 
    Enzon Inc. Reports Operating Results (10-K) Mar 16 2011 
    Carl Icahn Buys NAV, CHK, ENZN, AMLN, CMC, Feb 15 2011 
    Despite Bearish View, Seth Klarman Holds These Stocks: VSAT, THRX, NWSA, BBEP, ENZN, CSE Nov 25 2010 
    Enzon Inc. Reports Operating Results (10-Q) Nov 04 2010 

    More From Other Websites
    Nasdaq stocks posting largest volume increases Apr 23 2015
    Most active Nasdaq-traded stocks Apr 23 2015
    Most active Nasdaq-traded stocks Apr 23 2015
    Nasdaq stocks posting largest volume increases Apr 23 2015
    Voltari Corp (VLTC): Carl Icahn Stirring Yet Another Pot Apr 01 2015
    ENZON PHARMACEUTICALS INC Financials Mar 12 2015
    10-K for Enzon Pharmaceuticals, Inc. Mar 07 2015
    ENZON PHARMACEUTICALS INC Files SEC form 10-K, Annual Report Mar 05 2015
    ENZON PHARMACEUTICALS INC Files SEC form 8-K, Other Events Dec 10 2014
    ENZON PHARMACEUTICALS INC Files SEC form 8-K, Other Events Dec 05 2014
    ENZON PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report Nov 06 2014
    DELiA*s Rebounds As Reports Suggest Delisting May Be Imminent Nov 03 2014
    Bankruptcy Filing Fallout Continues For NII Holdings Sep 19 2014
    ENZON PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report Aug 08 2014
    Enzon regains compliance with Nasdaq Jul 16 2014
    ENZON PHARMACEUTICALS INC Files SEC form 8-K, Other Events Jul 16 2014
    Enzon Pharmaceuticals Inc Stock Upgraded (ENZN) Jul 08 2014
    ENZON PHARMACEUTICALS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued... Jun 12 2014
    ENZON PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders,... May 30 2014
    ENZON PHARMACEUTICALS INC Files SEC form 8-K, Other Events May 19 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    BasseyeNet@twitter
    ReplyBasseyeNet@twitter - 7 months ago
    Tangible Book Value:

    $ 0.47 Add to Fair Value


    Growth Value:$ 5.53


    Terminal Value: $ 3.47


    = Fair Value: $ 9
    BasseyeNet@twitter
    ReplyBasseyeNet@twitter - 7 months ago
    George Soros (Trades, Portfolio) just joined Carl Icahn (Trades, Portfolio) 2 months ago by adding ENZN to his portfolio...The 1yr price target is $14 on Yahoo finance.. Link below is a breakdown of the Billionaire's holding and adding to there positions in this company.

    http://www.gurufocus.com/gurutrades/ENZN#hold
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK